首页> 外文期刊>The Lancet infectious diseases >Persistent SARS-CoV-2 infection: the urgent need for access to treatment and trials
【24h】

Persistent SARS-CoV-2 infection: the urgent need for access to treatment and trials

机译:Persistent SARS-CoV-2 infection: the urgent need for access to treatment and trials

获取原文
获取原文并翻译 | 示例
           

著录项

  • 来源
    《The Lancet infectious diseases》 |2021年第10期|1345-1347|共3页
  • 作者单位

    North Bristol NHS Trust, Dept Infect Dis, Bristol, Avon, England;

    Royal United Hosp Bath NHS Fdn Trust, Dept Anaesthesia & Intens Care Med, Bath, Avon, England;

    Guys & St Thomas NHS Fdn Trust, Dept Infect, London, EnglandUniv Cambridge, Cambridge Inst Therapeut Immunol & Infect Dis, Cambridge, EnglandUniv Hosp Wales, Immunodef Ctr Wales, Cardiff, WalesUniv Cambridge, Div Anaesthesia, Cambridge, EnglandUniv Oxford, NHS Blood & Transplant & BRC Haematol Theme, Oxford, EnglandLeeds Teaching Hosp NHS Trust, Dept Clin Immunol & Allergy, Leeds, W Yorkshire, EnglandGuys & St Thomas NHS Fdn Trust, Dept Crit Care Med, London, EnglandUniv Coll London Hosp NHS Fdn Trust, Div Infect, London, EnglandLondon Sch Hyg & Trop Med, Dept Clin Res, London, England;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 英语
  • 中图分类 传染病;
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号